Insider · CIK 0001820365

Camardo Daniel A.

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001820365

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-09	CUECue Biopharma, Inc.A Award	Director	AAward	+21.8K sh	—	—	21,800
2026-05-30	CUECue Biopharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,626 sh	—	—	1,626
2023-10-04	ATHERSYS, INC / NEWF Tax Payment	Director, CEO	FTax Payment	−20K sh	$0.44	−$8,796.92	285,341
2023-07-05	ATHERSYS, INC / NEWF Tax Payment	Director, CEO	FTax Payment	−20K sh	$0.91	−$18.3K	305,334
2023-04-04	ATHERSYS, INC / NEWF Tax Payment	Director, CEO	FTax Payment	−20K sh	$1.00	−$20K	325,327
2023-01-04	ATHERSYS, INC / NEWF Tax Payment	Director, CEO	FTax Payment	−23.5K sh	$0.85	−$20K	345,320
2022-11-22	ATHERSYS, INC / NEWP Purchase	Director, CEO	PPurchase	+100K sh	$0.55	+$55K	368,804
2022-10-04	ATHERSYS, INC / NEWA Award	Director, CEO	AAward	+263K sh	—	—	268,804
2022-03-17	ATHERSYS, INC / NEWP Purchase	Director, CEO	PPurchase	+133K sh	$0.77	+$102K	132,800
2022-02-14	ATHERSYS, INC / NEWStock Option (right to purchase)A Award	Director, CEO	AAward	+4M sh	—	—	4,000,000
2021-04-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	+509 sh	$15.23	+$7,752.07	51,181
2021-04-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	+15.5K sh	$25.52	+$395K	50,672
2021-04-05	Horizon Therapeutics Public Ltd CoEmployee stock option (right to buy)M Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	−2,305 sh	—	—	0
2021-04-05	Horizon Therapeutics Public Ltd CoEmployee stock option (right to buy)M Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	−15.5K sh	—	—	4,333
2021-04-05	Horizon Therapeutics Public Ltd CoEmployee stock option (right to buy)M Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	−509 sh	—	—	3,441
2021-04-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	+2,305 sh	$17.19	+$39.6K	35,205
2021-03-30	Horizon Therapeutics Public Ltd CoS Sale	EVP and President, U.S.	SSale	−3,517 sh	$86.87	−$306K	32,900
2021-03-30	Horizon Therapeutics Public Ltd CoS Sale	EVP and President, U.S.	SSale	−1,803 sh	$83.58	−$151K	43,997
2021-03-30	Horizon Therapeutics Public Ltd CoS Sale	EVP and President, U.S.	SSale	−4,594 sh	$84.97	−$390K	39,403
2021-03-30	Horizon Therapeutics Public Ltd CoS Sale	EVP and President, U.S.	SSale	−2,986 sh	$85.88	−$256K	36,417
2021-02-21	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	+1,300 sh	—	—	46,376
2021-02-21	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	−1,300 sh	—	—	0
2021-02-21	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP and President, U.S.	FTax Payment	−576 sh	$88.87	−$51.2K	45,800
2021-01-21	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	+3,220 sh	—	—	46,503
2021-01-21	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)M Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	−3,220 sh	—	—	0
2021-01-21	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP and President, U.S.	FTax Payment	−1,427 sh	$77.43	−$110K	45,076
2021-01-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	+20.6K sh	—	—	52,513
2021-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	−10.6K sh	—	—	10,626
2021-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	−5,634 sh	—	—	0
2021-01-05	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP and President, U.S.	FTax Payment	−9,230 sh	$73.28	−$676K	43,283
2021-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	−4,354 sh	—	—	8,708
2021-01-04	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)A Award	EVP and President, U.S.	AAward	+21K sh	—	—	20,957
2020-11-06	Horizon Therapeutics Public Ltd CoS Sale	EVP and President, U.S.	SSale	−3,500 sh	$76.76	−$269K	30,829
2020-10-01	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP and President, U.S.	FTax Payment	−4,460 sh	$80.42	−$359K	34,329
2020-10-01	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	EVP and President, U.S.	MExercise/Conversion	−10K sh	—	—	0
2020-10-01	Horizon Therapeutics Public Ltd CoA Award	EVP and President, U.S.	AAward	+10K sh	—	—	38,789
2020-08-03	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)A Award	EVP and President, U.S.	AAward	−17.1K sh	—	—	17,102

Recent filings

Accepted (ET)
Jul 104
Camardo Daniel A.0001820365-26-000009
SEC(opens sec.gov)
Jun 84
Camardo Daniel A.0001820365-26-000006
SEC(opens sec.gov)
Oct 64
Camardo Daniel A.0001437749-23-027868
SEC(opens sec.gov)
Jul 64
Camardo Daniel A.0001368148-23-000069
SEC(opens sec.gov)
Apr 54
Camardo Daniel A.0001368148-23-000031
SEC(opens sec.gov)
Jan 64
Camardo Daniel A.0001368148-23-000007
SEC(opens sec.gov)
Nov 224
Camardo Daniel A.0001368148-22-000157
SEC(opens sec.gov)
Oct 64
Camardo Daniel A.0000899243-22-033112
SEC(opens sec.gov)
Mar 174
Camardo Daniel A.0001368148-22-000023
SEC(opens sec.gov)
Feb 144
Camardo Daniel A.0001368148-22-000010
SEC(opens sec.gov)
Apr 54
Camardo Daniel A.0001209191-21-025270
SEC(opens sec.gov)
Mar 314
Camardo Daniel A.0001209191-21-023819
SEC(opens sec.gov)

Companies

Address

C/O CUE BIOPHARMA, INC. 40 GUEST STREET

BOSTON, MA, 02135